Top 5 Earnings for the Week Ahead

Print Email

As the new earnings season is quickly approaching, 24/7 Wall St. has put together a preview of some of the notable companies reporting their quarterly results this week. We have included the consensus earnings estimates from Thomson Reuters and the stock price and trading history, as well as added some additional color on each.

Be advised that the earnings and revenue estimates may change ahead of the formal reports, and some companies may change reporting dates as well.

Micron Technology Inc. (NASDAQ: MU) will share its most recent quarterly results on Tuesday. The consensus estimates call for a net loss of $0.12 per share and $3.15 billion in revenue. Shares closed at $17.78 on Friday, in a 52-week trading range of $9.31 to $19.30. The stock has a consensus analyst price target of $18.71.

Darden Restaurants Inc. (NYSE: DRI) is scheduled to report its fiscal first-quarter results on Tuesday. The consensus analyst estimates call for $0.82 in earnings per share (EPS) and revenue of $1.72 billion. Shares of Darden closed at $61.32 on Friday. The consensus price target is $69.22. The 52-week range is $53.38 to $68.97.

Constellation Brands Inc. (NYSE: STZ) is expected to reveal its fiscal second-quarter results on Wednesday. The consensus estimates call for $1.65 in EPS, as well as $1.96 billion in revenue. Shares were trading at $166.49 on Friday’s close. The consensus price target is $179.94. The 52-week range is $126.00 to $168.68.

Yum! Brands Inc. (NYSE: YUM) is set to share its latest quarterly earnings on Wednesday. The consensus estimates call for $1.10 in EPS and $3.46 billion in revenue. Shares traded at $90.81 on Friday’s close, in a 52-week range of $64.58 to $91.99. The consensus price target is $91.55.

Monsanto Co. (NYSE: MON) will report its fiscal fourth-quarter results on Wednesday. The analysts’ consensus estimates call for a net loss of $0.02 per share and $2.38 billion in revenue. Shares were changing hands at $102.20 on Friday’s close. The consensus price target is $118.56, and the 52-week range is $83.73 to $114.26.